Miller Value Partners recently released its Q3 2020 Investor Letter, a copy of which you can download here. The Opportunity Equity Fund posted a return of 13.01% for the quarter (net of fees), outperforming its benchmark, the S&P 500 Index which returned 8.93% in the same quarter. You should check out Miller Value Partners’ top 5 stock picks for investors to buy right now, which could be the biggest winners of this year.
In the said letter, Miller Value Partners highlighted a few stocks and CVS Health Corp (NYSE:CVS) is one of them. CVS Health Corp (NYSE:CVS) is a healthcare company. Year-to-date, CVS Health Corp (NYSE:CVS) stock lost 21.8% and on November 2nd it had a closing price of $58.08. Here is what Miller Value Partners said:
“CVS is a name we owned earlier but exited in the COVID hit to deploy funds to names offering more significant near term recovery potential. CVS lagged in the ensuing recovery but we still think it’s an undervalued mix of businesses. If you value you the pieces, a healthcare insurance company, a pharmacy benefits manager, and a retail pharmacy, you get values roughly 50% greater than the current stock price. We think its vertical integration strategy around lowering the cost of healthcare through “Health Hubs” offers you free option value at current prices. We used long-term call options which we thought offered favorable risk-return.”
![30 Funniest Science Jokes, Puns, and Humor Quotes Ever](https://imonkey-blog.imgix.net/blog/wp-content/uploads/2017/03/04134859/shutterstock_418744579.jpg?auto=fortmat&fit=clip&expires=1755993600&width=480&height=320)
pikselstock/Shutterstock.com
Last month, we published an article revealing that VLTAVA Fund is bullish on CVS Health Corp (NYSE:CVS) stock. The fund is tracking the CVS stock since a long time.
In Q2 2020, the number of bullish hedge fund positions on CVS Health Corp (NYSE:CVS) stock decreased by about 8% from the previous quarter (see the chart here), so a number of other hedge fund managers don’t believe in CVS’s growth potential. Our calculations showed that CVS Health Corp (NYSE:CVS) isn’t ranked among the 30 most popular stocks among hedge funds.
The top 10 stocks among hedge funds returned 185% since the end of 2014 and outperformed the S&P 500 Index ETFs by more than 109 percentage points. We know it sounds unbelievable. You have been dismissing our articles about top hedge fund stocks mostly because you were fed biased information by other media outlets about hedge funds’ poor performance. You could have doubled the size of your nest egg by investing in the top hedge fund stocks instead of dumb S&P 500 ETFs. Below you can watch our video about the top 5 hedge fund stocks right now. All of these stocks had positive returns in 2020.
Video: Top 5 Stocks Among Hedge Funds
At Insider Monkey we scour multiple sources to uncover the next great investment idea. For example, lithium mining is one of the fastest growing industries right now, so we are checking out stock pitches like this emerging lithium stock. We go through lists like the 10 most profitable companies in the world to pick the best large-cap stocks to buy. Even though we recommend positions in only a tiny fraction of the companies we analyze, we check out as many stocks as we can. We read hedge fund investor letters and listen to stock pitches at hedge fund conferences. You can subscribe to our free daily newsletter on our website:
Disclosure: None. This article is originally published at Insider Monkey.